4.2 Article

hsa_circ_0139402 Promotes Bladder Cancer Progression by Regulating hsa-miR-326/PAX8 Signaling

Journal

DISEASE MARKERS
Volume 2022, Issue -, Pages -

Publisher

HINDAWI LTD
DOI: 10.1155/2022/9899548

Keywords

-

Funding

  1. Basic medical subject team [JDXKTD-2019002]

Ask authors/readers for more resources

This study reveals that hsa_circ_0139402 is highly expressed in bladder cancer tissues, especially in metastatic tissues. Functional assays suggest that hsa_circ_0139402 enhances the proliferation, migration, and invasion of bladder cancer cells by targeting PAX8 via hsa-miR-326. These findings provide a potential therapeutic target for early diagnosis and treatment of bladder cancer.
Background. Bladder cancer (BC) is a malignant and common malignant tumors. However, the prognosis of most patients with bladder cancer is still poor, and it is particularly important to identify early tumor diagnostic and treatment targets. Materials and Methods. High-throughput sequencing was used to evaluate the expression level of circRNA in bladder cancer tissue. MTT assay, wound healing assay, and transwell assay were used to detect the cancer cells' proliferation, migration, and invasion affected by hsa_circ_0139402. The possible miRNA targets of hsa_circ_0139402 and downstream genes were detected by bioinformatics methods and dual-luciferase reporting experiment. FISH was used to observe their interaction. Results. High-throughput sequencing result showed that the expression of hsa_circ_0139402 was highest in BC tissues and increased in metastatic tissues compared to that of nonmetastatic tissues. MTT assay, wound healing assay, and transwell assay revealed that sh-hsa_circ_0139402 could suppress BC cells' proliferation, invasion, and migration. Bioinformatics analysis, dual-luciferase reporter, and RIP assay showed that hsa_circ_0139402 can bind to hsa-miR-326, and PAX8 is a direct target of hsa-miR-326 in BC cell. Further, cytological studies found that hsa_circ_0139402 enhances BC cells' proliferation, migration, and invasion by targeting PAX8 via hsa-miR-326. Conclusion. hsa_circ_0139402 plays a oncogene in BC and that can effectively promote cell proliferation, migration, invasion, and EMT by targeting Paired Box Protein Pax-8 (PAX8) via hsa-miR-326 and provides a potential therapeutic target for BC patients.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

The biologically functional identification of a novel TIM3-binding peptide P26 in vitro and in vivo

Tangwu Zhong, Chuanke Zhao, Shuntao Wang, Deshuang Tao, Shuxia Ma, Chengchao Shou

CANCER CHEMOTHERAPY AND PHARMACOLOGY (2020)

Article Oncology

EGR1/LINC00839/SOX5 axis modulates migration, invasion and Gemcitabine resistance of bladder cancer cells

Zunxian Wang, Bo Wei, Shuxia Ma

Summary: This study identifies a coherent feed-forward loop involving EGR1, LINC00839/miR-142, and SOX5 that modulates the migration, invasion, and Gemcitabine resistance of bladder cancer.

CANCER BIOLOGY & THERAPY (2023)

No Data Available